Galaxy Surfactants (GALAXYSURF)₹2,197−1.22%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Galaxy Surfactants reported sales of ₹1,776 Cr, up 39.5% from Jun 2025, and net profit of ₹165 Cr, up 110.2% year on year. For the year to Mar 2026, sales were ₹5,225 Cr and net profit ₹266 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 980 | 936 | 925 | 971 | 1,059 | 1,038 | 1,140 | 1,273 | 1,322 | 1,323 | 1,310 | 1,776 |
| Expenses | 858 | 829 | 828 | 850 | 936 | 936 | 1,018 | 1,154 | 1,216 | 1,211 | 1,193 | 1,534 |
| Operating Profit | 125 | 112 | 102 | 124 | 128 | 106 | 127 | 124 | 110 | 119 | 122 | 249 |
| OPM % | 13.0% | 12.0% | 11.0% | 12.9% | 11.9% | 10.0% | 10.9% | 10.0% | 7.9% | 9.0% | 8.9% | 13.9% |
| Other Income | 3.01 | 6.01 | 24.03 | 4.99 | 9.01 | 3.99 | 8.01 | 11.01 | 6.01 | −7.01 | 0.00 | 3.01 |
| Interest | 5.02 | 6.02 | 5.02 | 4.02 | 4.01 | 5.02 | 6.02 | 7.03 | 7.02 | 9.03 | 8.04 | 9.03 |
| Depreciation | 25.09 | 25.08 | 26.09 | 27.09 | 28.11 | 28.09 | 28.11 | 29.07 | 30.11 | 31.07 | 33.10 | 36.09 |
| Profit before tax | 98.39 | 88.37 | 94.32 | 99.32 | 104 | 77.36 | 100 | 99.38 | 79.25 | 73.28 | 80.35 | 208 |
| Tax % | 21.0% | 19.0% | 18.0% | 19.0% | 19.0% | 16.0% | 24.0% | 20.0% | 16.0% | 19.0% | 22.0% | 20.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −9.99 | 0.00 | 0.00 |
| Net Profit | 76.66 | 70.69 | 77.68 | 79.66 | 84.68 | 64.74 | 75.74 | 78.71 | 65.78 | 58.75 | 61.75 | 165 |
| EPS (Rs) | 21.86 | 20.14 | 21.85 | 22.50 | 23.90 | 18.23 | 21.42 | 22.41 | 18.76 | 16.65 | 17.60 | 46.84 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,793 | 2,150 | 2,421 | 2,751 | 2,587 | 2,774 | 3,668 | 4,447 | 3,776 | 4,204 | 5,225 | 5,731 |
| Expenses | 1,564 | 1,886 | 2,144 | 2,407 | 2,227 | 2,336 | 3,287 | 3,894 | 3,333 | 3,736 | 4,777 | 5,155 |
| Operating Profit | 236 | 271 | 288 | 352 | 368 | 448 | 400 | 567 | 461 | 483 | 467 | 599 |
| OPM % | 13.0% | 12.9% | 11.9% | 12.9% | 13.9% | 15.9% | 10.9% | 12.9% | 12.0% | 10.9% | 8.9% | 10.5% |
| Other Income | 6.01 | 10.01 | 9.99 | 5.01 | 6.01 | 11.01 | 12.99 | 10.01 | 35.04 | 26.01 | 18.01 | 2.01 |
| Interest | 34.14 | 27.09 | 31.13 | 30.13 | 24.10 | 13.05 | 13.05 | 22.09 | 22.07 | 19.08 | 31.14 | 33.12 |
| Depreciation | 45.16 | 47.18 | 49.14 | 51.18 | 62.20 | 74.26 | 71.17 | 83.23 | 100 | 110 | 123 | 130 |
| Profit before tax | 164 | 208 | 220 | 278 | 290 | 373 | 330 | 475 | 376 | 382 | 333 | 441 |
| Tax % | 37.0% | 29.0% | 28.0% | 31.0% | 20.0% | 19.0% | 20.0% | 19.0% | 20.0% | 20.0% | 19.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | −0.99 | −0.99 | −0.99 | −0.99 | −0.99 | −0.99 | −0.99 | −10.99 | −9.99 |
| Net Profit | 103 | 147 | 157 | 190 | 229 | 301 | 262 | 379 | 300 | 304 | 266 | 352 |
| EPS (Rs) | 28.98 | 41.65 | 44.59 | 53.85 | 65.02 | 85.24 | 74.14 | 107.41 | 84.99 | 86.07 | 75.40 | 99.85 |
| Dividend payout % | 31.1% | 14.1% | 16.1% | 15.1% | 22.1% | 21.1% | 24.1% | 20.1% | 26.1% | 5.1% | 29.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35.11 | 35.12 | 35.12 | 35.14 | 35.11 | 35.11 | 35.13 | 35.10 | 35.12 | 35.11 | 35.12 | 35.12 |
| Reserves | 342 | 411 | 538 | 683 | 840 | 1,032 | 1,266 | 1,537 | 1,845 | 2,143 | 2,326 | 2,706 |
| Borrowings | 451 | 412 | 392 | 347 | 298 | 395 | 289 | 420 | 326 | 187 | 210 | 235 |
| Other Liabilities | 232 | 251 | 316 | 387 | 391 | 349 | 459 | 605 | 520 | 542 | 881 | 889 |
| Total Liabilities | 1,061 | 1,109 | 1,283 | 1,453 | 1,564 | 1,812 | 2,049 | 2,598 | 2,728 | 2,907 | 3,453 | 3,866 |
| Fixed Assets | 459 | 436 | 456 | 447 | 519 | 749 | 712 | 760 | 924 | 973 | 1,031 | 1,175 |
| CWIP | 7.03 | 51.17 | 10.04 | 25.09 | 83.25 | 66.23 | 124 | 206 | 139 | 158 | 263 | 182 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.01 | 42.98 | 0.00 | 0.00 | 198 | 299 | 474 |
| Other Assets | 594 | 622 | 817 | 981 | 963 | 992 | 1,169 | 1,630 | 1,663 | 1,576 | 1,860 | 2,035 |
| Inventories | 246 | 237 | 318 | 347 | 351 | 326 | 429 | 713 | 647 | 557 | 725 | 795 |
| Trade receivables | 221 | 250 | 347 | 417 | 426 | 438 | 468 | 637 | 614 | 592 | 685 | 748 |
| Cash & equivalents | 18.99 | 15.99 | 25.98 | 27.98 | 26.01 | 54.03 | 111 | 71.03 | 248 | 239 | 216 | 275 |
| Total Assets | 1,061 | 1,109 | 1,283 | 1,453 | 1,564 | 1,812 | 2,049 | 2,598 | 2,728 | 2,907 | 3,453 | 3,866 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 41.06 | 170 | 111 | 145 | 284 | 316 | 365 | 5.01 | 574 | 519 | 422 | 334 |
| Cash from investing activity | −26.06 | −59.17 | −43.12 | −54.15 | −166 | −149 | −166 | −82.15 | −141 | −342 | −291 | −367 |
| Cash from financing activity | −17.01 | −110 | −56.99 | −90.05 | −119 | −144 | −165 | 59.02 | −264 | −189 | −157 | −51.03 |
| Net cash flow | −1.99 | 0.00 | 10.98 | 0.99 | −1.99 | 22.95 | 33.94 | −17.97 | 168 | −10.99 | −26.94 | −83.92 |
| Capex | 25.98 | 61.97 | 42.93 | 56.90 | 169 | 142 | 108 | 155 | 146 | 158 | 219 | 137 |
| Free cash flow | 14.99 | 116 | 67.97 | 88.97 | 115 | 174 | 258 | −150 | 429 | 362 | 205 | 198 |
| CFO / OP % | 49.1% | 98.1% | 62.0% | 71.1% | 101.0% | 104.0% | 97.0% | 16.1% | 118.0% | 129.1% | 101.1% | 86.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 43 | 51 | 59 | 63 | 56 | 62 | 62 | 63 | 50 | 57 | 59 | 52 |
| Inventory days | 68 | 72 | 79 | 75 | 68 | 72 | 91 | 103 | 78 | 82 | 95 | 76 |
| Days payable | 49 | 58 | 62 | 70 | 58 | 59 | 79 | 74 | 51 | 65 | 80 | 61 |
| Cash conversion cycle | 60 | 63 | 74 | 66 | 64 | 72 | 71 | 90 | 75 | 72 | 72 | 65 |
| Working capital days | 4 | 27 | 31 | 39 | 41 | 43 | 50 | 63 | 55 | 64 | 52 | 47 |
| ROCE % | — | 22.9% | 26.0% | 24.9% | 28.0% | 24.0% | 24.9% | 18.9% | 23.9% | 16.9% | 15.9% | 13.9% |
For the Jun 2026 quarter, Galaxy Surfactants reported sales of ₹1,776 Cr, up 39.5% year on year and net profit of ₹165 Cr, up 110.2% year on year. The operating margin was 13.9%.
Galaxy Surfactants' sales for the year to Mar 2026 were ₹5,225 Cr; over the last twelve months they were ₹5,731 Cr.
Net profit for the year to Mar 2026 was ₹266 Cr, and ₹352 Cr over the last twelve months. Earnings per share over the same trailing period were ₹99.85.
Galaxy Surfactants reported borrowings of ₹235 Cr at Mar 2026, against cash and equivalents of ₹275 Cr.
Cash from operations was ₹334 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹198 Cr.